Metraipolis › archive › dc_d8963ea33510

Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors in malignant solid tumors: a meta-analysis and network meta-analysis — Europe PMC PMID:41953011

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41953011
DOI: 10.3389/fimmu.2026.1780636
License (as archived): solo-consultazione
Archived: 2026-11-03T23:39:10.961Z
SHA-256 of the archived text: 788903e56395baa17b509bd64f44c25fd6cdbebe347e029e7355d3feb076fea2
Stable URL of this page: https://metraipolis.com/documento/dc_d8963ea33510

How to cite

Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors in malignant solid tumors: a meta-analysis and network meta-analysis — Europe PMC PMID:41953011 — Europe PMC (en), https://europepmc.org/article/MED/41953011 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8963ea33510 (Metraipolis archive dc_d8963ea33510, sha256 788903e56395baa17b509bd64f44c25fd6cdbebe347e029e7355d3feb076fea2)

BibTeX

@misc{dcd8963ea33510,
  title = {Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors in malignant solid tumors: a meta-analysis and network meta-analysis — Europe PMC PMID:41953011},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41953011},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8963ea33510; sha256 788903e56395baa17b509bd64f44c25fd6cdbebe347e029e7355d3feb076fea2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41953011. Agents can read the archived copy with the MCP tool read_document.